• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征 21 号染色体三体的产前筛查:不同筛查策略的比较性能和成本分析。

Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies.

机构信息

Genetics Program, North York General Hospital, 4001 Leslie Street, Toronto, Ontario, M2K 1E1, Canada.

Prenatal Screening Ontario, Better Outcomes Registry & Network (BORN) Ontario, Ottawa, Ontario, Canada.

出版信息

BMC Pregnancy Childbirth. 2020 Nov 23;20(1):713. doi: 10.1186/s12884-020-03394-w.

DOI:10.1186/s12884-020-03394-w
PMID:33228595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7686697/
Abstract

BACKGROUND

Prenatal screening for chromosome aneuploidies have constantly been evolving, especially with the introduction of cell-free fetal DNA (cfDNA) screening in the most recent years. This study compares the performance, costs and timing of test results of three cfDNA screening implementation strategies: contingent, reflex and primary.

METHODS

We modelled enhanced first trimester screening (eFTS) as the first-tier test in contingent or reflex strategies. cfDNA test was performed contingent on or reflex from eFTS results. A comparison was made between cfDNA screening using sequencing technology and Rolling Circle Amplification (RCA)/imaging solution. All model assumptions were based on results from previous publications or information from the Ontario prenatal screening population.

RESULTS

At an eFTS risk cut-off of ≥1/1000, contingent and reflex cfDNA screening have the same detection rate (DR) (94%) for trisomy 21. Reflex cfDNA screening using RCA/Imaging solution provided the lowest false positive rate and cost. The number of women requiring genetic counselling and diagnostic testing was significantly reduced and women received their cfDNA screening result 9 days sooner compared with the contingent model. While primary cfDNA screening improved the trisomy 21 DR by 3-5%, it was more costly and more women required diagnostic testing.

CONCLUSION

Reflex cfDNA screening is the most cost-effective prenatal screening strategy. It can improve the efficiency of prenatal aneuploidy screening by reducing the number of patient visits and providing more timely results.

摘要

背景

染色体非整倍体的产前筛查一直在不断发展,尤其是近年来引入了游离胎儿 DNA(cfDNA)筛查。本研究比较了三种 cfDNA 筛查实施策略的性能、成本和检测结果时间:有条件的、反射的和主要的。

方法

我们将增强型早期筛查(eFTS)作为有条件或反射策略的一线检测。cfDNA 检测根据 eFTS 结果进行有条件或反射。比较了使用测序技术和滚环扩增(RCA)/成像解决方案的 cfDNA 筛查。所有模型假设均基于之前的出版物结果或安大略省产前筛查人群的信息。

结果

在 eFTS 风险截止值≥1/1000 时,有条件和反射 cfDNA 筛查对 21 三体的检测率(DR)相同(94%)。使用 RCA/成像解决方案的反射 cfDNA 筛查提供了最低的假阳性率和成本。需要遗传咨询和诊断测试的妇女人数显著减少,与有条件模型相比,妇女更早获得 cfDNA 筛查结果(提前 9 天)。虽然主要的 cfDNA 筛查提高了 21 三体的 DR 3-5%,但它的成本更高,需要更多的妇女进行诊断测试。

结论

反射 cfDNA 筛查是最具成本效益的产前筛查策略。它可以通过减少患者就诊次数和提供更及时的结果来提高产前非整倍体筛查的效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0331/7686697/3affb8249eae/12884_2020_3394_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0331/7686697/3affb8249eae/12884_2020_3394_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0331/7686697/3affb8249eae/12884_2020_3394_Fig1_HTML.jpg

相似文献

1
Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies.唐氏综合征 21 号染色体三体的产前筛查:不同筛查策略的比较性能和成本分析。
BMC Pregnancy Childbirth. 2020 Nov 23;20(1):713. doi: 10.1186/s12884-020-03394-w.
2
Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study.应用游离胎儿 DNA contingent 筛查策略进行三体综合征的临床研究:一项初步研究。
BMC Pregnancy Childbirth. 2019 Aug 1;19(1):274. doi: 10.1186/s12884-019-2434-0.
3
Contingent cfDNA Screening Implementation: Increasing Diagnostic Accuracy and Reducing Invasive Testing - 6 Years' Results in a Single Center.基于游离 DNA 的有条件检测实施:提高诊断准确率,减少侵入性检测-单中心 6 年结果
Fetal Diagn Ther. 2022;49(3):103-113. doi: 10.1159/000523848. Epub 2022 Mar 8.
4
Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.在丹麦临床环境中使用游离胎儿 DNA 进行有条件的早孕期筛查非整倍体。
Ultrasound Obstet Gynecol. 2018 Apr;51(4):470-479. doi: 10.1002/uog.17562. Epub 2018 Mar 4.
5
Prenatal screening for fetal aneuploidy in singleton pregnancies.单胎妊娠胎儿非整倍体的产前筛查。
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
6
Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.英国国民医疗服务体系(NHS)中胎儿三体综合征常规筛查的临床实施:基于孕早期联合检测结果的游离DNA检测
Ultrasound Obstet Gynecol. 2016 Jan;47(1):45-52. doi: 10.1002/uog.15783. Epub 2015 Oct 26.
7
Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.双胎妊娠胎儿三体的常规早孕期筛查:游离 DNA 检测取决于联合检测的结果。
Ultrasound Obstet Gynecol. 2019 Feb;53(2):208-213. doi: 10.1002/uog.20160. Epub 2018 Dec 7.
8
[MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].[母体血清筛查试验中游离胎儿DNA临床应用模型分析]
Akush Ginekol (Sofiia). 2015;54(7):15-21.
9
DNA sequencing versus standard prenatal aneuploidy screening.DNA 测序与标准产前非整倍体筛查。
N Engl J Med. 2014 Feb 27;370(9):799-808. doi: 10.1056/NEJMoa1311037.
10
Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.游离胎儿 DNA 检测在三胎妊娠常见胎儿三体中的表现。
Prenat Diagn. 2024 May;44(5):555-561. doi: 10.1002/pd.6548. Epub 2024 Mar 6.

引用本文的文献

1
Systematic Review of Accuracy Differences in NIPT Methods for Common Aneuploidy Screening.常见非整倍体筛查中无创产前检测方法准确性差异的系统评价
J Clin Med. 2025 Apr 18;14(8):2813. doi: 10.3390/jcm14082813.
2
Improved contingent screening strategy increased trisomy 21 detection rate in the second trimester.改良的偶然筛查策略提高了孕中期21三体综合征的检出率。
Arch Gynecol Obstet. 2025 Apr;311(4):1029-1037. doi: 10.1007/s00404-024-07743-4. Epub 2024 Sep 21.
3
Impact of Structural Differences on the Modeled Cost-Effectiveness of Noninvasive Prenatal Testing.

本文引用的文献

1
Clinical validation of a novel automated cell-free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma.一种新型的用于母体外周血中 21、13、18 三体的全自动游离 DNA 筛查检测的临床验证。
Prenat Diagn. 2019 Oct;39(11):1011-1015. doi: 10.1002/pd.5528. Epub 2019 Aug 19.
2
Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13.产前召回和反射 DNA 筛查 21 三体、18 三体和 13 三体的成本效益比较。
PLoS One. 2019 Jul 25;14(7):e0220053. doi: 10.1371/journal.pone.0220053. eCollection 2019.
3
The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysis.
结构差异对无创性产前检测模型成本效益的影响。
Med Decis Making. 2024 Oct;44(7):811-827. doi: 10.1177/0272989X241263368. Epub 2024 Aug 2.
4
Analysis of Down syndrome newborn outcomes in three neonatal intensive care units in Rio de Janeiro, Brazil.巴西里约热内卢三家新生儿重症监护病房唐氏综合征新生儿结局分析
Rev Assoc Med Bras (1992). 2024 Apr 22;70(3):e20231186. doi: 10.1590/1806-9282.20231186. eCollection 2024.
5
Economic evaluations of predictive genetic testing: A scoping review.预测性基因检测的经济学评价:范围综述。
PLoS One. 2023 Aug 2;18(8):e0276572. doi: 10.1371/journal.pone.0276572. eCollection 2023.
6
Non-Invasive prenatal testing with rolling circle amplification: Real-world clinical experience in a non-molecular laboratory.滚环扩增的无创性产前检测:非分子实验室的真实临床经验。
J Clin Lab Anal. 2023 Mar;37(6):e24870. doi: 10.1002/jcla.24870. Epub 2023 Mar 27.
7
Maternal prenatal screening programs that predict trisomy 21, trisomy 18, and neural tube defects in offspring.母孕期产前筛查项目可预测胎儿的 21 三体、18 三体综合征和神经管缺陷。
PLoS One. 2023 Feb 21;18(2):e0281201. doi: 10.1371/journal.pone.0281201. eCollection 2023.
8
False-positives and false-negatives in non-invasive prenatal testing (NIPT): what can we learn from a meta-analyses on > 750,000 tests?无创产前检测(NIPT)中的假阳性和假阴性:从超过750,000次检测的荟萃分析中我们能学到什么?
Mol Cytogenet. 2022 Aug 19;15(1):36. doi: 10.1186/s13039-022-00612-2.
9
A Cost-Effectiveness Analysis of Screening Strategies Involving Non-Invasive Prenatal Testing for Trisomy 21.非侵入性产前检测用于 21 三体综合征筛查策略的成本效果分析。
Front Public Health. 2022 May 31;10:870543. doi: 10.3389/fpubh.2022.870543. eCollection 2022.
10
Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.基于非下一代测序的无创性产前检测技术的评估及临床应用。
Curr Issues Mol Biol. 2021 Aug 17;43(2):958-964. doi: 10.3390/cimb43020068.
在西班牙国家医疗服务体系中采用游离胎儿DNA进行无创产前检测以检测唐氏综合征的后果:一项成本效益分析
Cost Eff Resour Alloc. 2019 Mar 1;17:6. doi: 10.1186/s12962-019-0173-8. eCollection 2019.
4
Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing.产前游离 DNA 筛查检测失败:失败率、唐氏综合征风险及重复检测影响的系统综述。
Genet Med. 2018 Nov;20(11):1312-1323. doi: 10.1038/gim.2018.22. Epub 2018 Apr 26.
5
Enhanced First Trimester Aneuploidy Screening with Placental Growth Factor and Alpha Feto-Protein: Detection of Trisomies 18 and 13.利用胎盘生长因子和甲胎蛋白进行孕早期强化非整倍体筛查:18三体和13三体的检测
J Obstet Gynaecol Can. 2018 Oct;40(10):1295-1301. doi: 10.1016/j.jogc.2018.01.007. Epub 2018 Jul 17.
6
Imaging single DNA molecules for high precision NIPT.对单个 DNA 分子进行成像,以实现高精度的无创产前检测。
Sci Rep. 2018 Mar 14;8(1):4549. doi: 10.1038/s41598-018-22606-0.
7
Prenatal diagnosis and socioeconomic status in the non-invasive prenatal testing era: A population-based study.无创产前检测时代的产前诊断与社会经济地位:一项基于人群的研究
Aust N Z J Obstet Gynaecol. 2018 Aug;58(4):404-410. doi: 10.1111/ajo.12778. Epub 2018 Jan 30.
8
Prenatal reflex DNA screening for trisomies 21, 18, and 13.产前反射性 DNA 筛查 21、18 和 13 三体综合征。
Genet Med. 2018 Aug;20(8):825-830. doi: 10.1038/gim.2017.188. Epub 2017 Nov 9.
9
Enhanced First Trimester Screening for Trisomy 21 with Contingent Cell-Free Fetal DNA: A Comparative Performance and Cost Analysis.采用游离胎儿DNA进行21三体妊娠早期强化筛查:性能与成本比较分析
J Obstet Gynaecol Can. 2017 Sep;39(9):742-749. doi: 10.1016/j.jogc.2017.01.025. Epub 2017 Jun 16.
10
cfDNA screening performance: accounting for and reducing test failures.循环游离DNA筛查性能:考虑并减少检测失败情况
Ultrasound Obstet Gynecol. 2017 Jun;49(6):689-692. doi: 10.1002/uog.17492.